Project ALS is pleased to share that the FDA has approved the drug edaravone – the first approved ALS treatment in over 20 years.
Edaravone, a free radical scavenger, appears to react with nerve-damaging compounds generated as part of the disease process. After six months of treatment, on top of standard-of-care, data showed the intravenous drug reduced the rate of functional decline in patients by about a third.
Read more
Project ALS Research LIVE: The Beginning Years
Project ALS Research LIVE: 25 Years of ProgressThe Beginning Years https://vimeo.com/794198397 Go back in time with those who were pivotal in changing the landscape of
February 2, 2023
No Comments
